L
Lloyd R. Sutherland
Researcher at University of Calgary
Publications - 137
Citations - 14183
Lloyd R. Sutherland is an academic researcher from University of Calgary. The author has contributed to research in topics: Crohn's disease & Placebo. The author has an hindex of 47, co-authored 137 publications receiving 13684 citations. Previous affiliations of Lloyd R. Sutherland include Université de Montréal & Alberta Health Services.
Papers
More filters
Journal ArticleDOI
A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998.
Christoph Gasche,Jürgen Schölmerich,Jørn Brynskov,Geert D'Haens,Stephen B. Hanauer,E. Jan Irvine,Derek P. Jewell,Daniel Rachmilewitz,David B. Sachar,William J. Sandborn,Lloyd R. Sutherland +10 more
TL;DR: The aim of this international Working Party was to develop a simple classification of Crohn's disease based on objective variables, and the allocation of patients to these 24 subgroups proved feasible and resulted in specific disease clusters.
Journal ArticleDOI
A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis.
Geert D'Haens,William J. Sandborn,Brian G. Feagan,Karel Geboes,Stephen B. Hanauer,E. Jan Irvine,Marc Lémann,Philippe Marteau,Paul Rutgeerts,Jürgen Schölmerich,Lloyd R. Sutherland +10 more
TL;DR: The results were summarized in a draft manuscript by the primary authors (G.D. and W.J. as discussed by the authors ) and discussed at the annual IOIBD meetings in 2004 and 2005.
Journal ArticleDOI
Azathioprine and 6-Mercaptopurine in Crohn Disease: A Meta-Analysis
TL;DR: Azathioprine and 6-mercaptopurine are effective in treating active Crohn disease and in maintaining remission of quiescent disease as mentioned in this paper, however, adverse effects were more common among patients receiving therapy.
Journal ArticleDOI
Methotrexate for the Treatment of Crohn's Disease
Brian G. Feagan,J. Rochon,Richard N. Fedorak,E J Irvine,Gary Wild,Lloyd R. Sutherland,A H Steinhart,Gordon R. Greenberg,R Gillies,Marybeth Hopkins +9 more
TL;DR: In a group of patients with chronically active Crohn's disease, methotrexate was more effective than placebo in improving symptoms and reducing requirements for prednisone.
Journal ArticleDOI
A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators.
Brian G. Feagan,Richard N. Fedorak,E J Irvine,Gary Wild,Lloyd R. Sutherland,A H Steinhart,Gordon R. Greenberg,John J. Koval,Cindy J. Wong,Marybeth Hopkins,Stephen B. Hanauer,John W.D. McDonald +11 more
TL;DR: In patients with Crohn's disease who enter remission after treatment with methotrexate, a low dose of methotRexate maintains remission.